SEI Investments’s aTyr Pharma ATYR Stock Holding History

SEI Investments’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,829	Closed	-$26.4K	–	3421
2026 Q1	$26.4K	Hold	33,829	–	–	﹤0.01%	3208
2025 Q4	$26.5K	Hold	33,829	–	–	﹤0.01%	3109
2025 Q3	$24.4K	Buy	+33,829	New	+$153K	﹤0.01%	2809

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SEI Investments's ATYR Position: Q2 2026 in Review

SEI Investments sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 33,829 shares — an estimated $26.4K sold.

SEI Investments first reported a position in ATYR in Q3 2025 and held it in 3 quarters. The position peaked at $26.5K in Q4 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

SEI Investments reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
SEI Investments sold 33,829 aTyr Pharma shares in Q2 2026, an estimated $26.4K.
SEI Investments first reported a position in aTyr Pharma in Q3 2025 and held it in 3 quarters.
SEI Investments's aTyr Pharma position peaked at $26.5K in Q4 2025.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.